AMC
AMC Entertainment Holdings, Inc.
AMC has the edge over CDLX overall, supported by stronger fundamentals and lower modeled downside.
CDLX
Cardlytics, Inc.
CDLX trails on the overall score without a compensating advantage in the available component scores.
AMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Under pressure |
AMC's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is under pressure.
CDLX Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Unavailable |
CDLX's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
AMC PE Valuation
AMC has no meaningful PE right now: it lost money over the past year.
CDLX PE Valuation
CDLX has no meaningful PE right now: it lost money over the past year.
AMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
AMC has the edge over CDLX on the outlook, with more favorable revenue expectations.
CDLX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CDLX's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
AMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | +$0.94 |
| Q2 2026 | -$1.10 | -$0.28 |
| Q1 2026 | -$1.09 | -$0.18 |
| Q4 2025 | -$1.34 | -$0.28 |
| Q3 2025 | -$1.34 | +$0.29 |
| Q2 2025 | -$0.82 | +$0.67 |
| Q1 2025 | -$0.91 | +$0.38 |
| Q4 2024 | -$1.06 | +$1.31 |
AMC lost $0.40 per share over the past year, a smaller loss than the year before.
CDLX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$6.42 | +$15.18 |
| Q2 2026 | -$18.50 | +$18.50 |
| Q1 2026 | -$17.72 | +$18.38 |
| Q4 2025 | -$19.50 | +$19.60 |
| Q3 2025 | -$21.60 | +$40.45 |
| Q2 2025 | -$37.00 | +$2.35 |
| Q1 2025 | -$36.10 | +$9.05 |
| Q4 2024 | -$39.10 | -$3.55 |
CDLX has the edge over AMC on earnings, with more consistent year-over-year improvement.
AMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +32% |
| Q2 2026 | $1.6B | +14% |
| Q1 2026 | $1B | +21% |
| Q4 2025 | $1.3B | -1.4% |
| Q3 2025 | $1.3B | -3.6% |
| Q2 2025 | $1.4B | +36% |
| Q1 2025 | $862.5M | -9.3% |
| Q4 2024 | $1.3B | +18% |
AMC has the edge over CDLX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +12 points |
| Q2 2026 | 15% | +8.3 points |
| Q1 2026 | -4.4% | +13 points |
| Q4 2025 | 0% | -0.3 points |
| Q3 2025 | 2.8% | -2.6 points |
| Q2 2025 | 6.6% | +11 points |
| Q1 2025 | -17% | -5.5 points |
| Q4 2024 | 0.4% | +14 points |
AMC has the edge over CDLX on profitability, with a higher operating margin.
CDLX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32.9M | -37% |
| Q2 2026 | $36.9M | -42% |
| Q1 2026 | $34.3M | -45% |
| Q4 2025 | $56.1M | -24% |
| Q3 2025 | $52M | -22% |
| Q2 2025 | $63.2M | -9.2% |
| Q1 2025 | $61.9M | -8.4% |
| Q4 2024 | $74M | -17% |
CDLX's revenue has slid since its 2021 peak: $33M last quarter, down 37% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -16% | +116 points |
| Q2 2026 | -15% | +5.5 points |
| Q1 2026 | -24% | -1.4 points |
| Q4 2025 | -11% | +0.4 points |
| Q3 2025 | -132% | +89 points |
| Q2 2025 | -20% | +2.5 points |
| Q1 2025 | -23% | +11 points |
| Q4 2024 | -11% | +104 points |
CDLX's operating margin was −16% last quarter, up 116 points from the same quarter a year ago.
AMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $109.3M | +$190.4M |
| Q2 2026 | $190.1M | +114% |
| Q1 2026 | -$174.7M | +$242.3M |
| Q4 2025 | $43.3M | -62% |
| Q3 2025 | -$81.1M | +$11.1M |
| Q2 2025 | $88.9M | +$168.1M |
| Q1 2025 | -$417M | -$178.2M |
| Q4 2024 | $113.9M | +$263.8M |
AMC has the edge over CDLX on cash generation, producing positive trailing cash flow while its opponent burns cash.
CDLX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.9M | -439% |
| Q2 2026 | -$8.6M | -1052% |
| Q1 2026 | -$5.7M | +$1.2M |
| Q4 2025 | $13M | +355% |
| Q3 2025 | $1.7M | +99% |
| Q2 2025 | $903K | -78% |
| Q1 2025 | -$6.8M | +$11.4M |
| Q4 2024 | $2.9M | +7.4% |
CDLX's free cash flow was −$7M over the past year, against −$1M the year before.
AMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 12.2x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 10.7x | High |
| Q1 2025 | 18.6x | High |
| Q4 2024 | 14.3x | High |
AMC's net debt is about 4.0 years of its operating earnings (EBITDA), down from 12 years a year ago.
CDLX Net Leverage
CDLX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 65.4 | Neutral |
AMC's weekly RSI is 67 (neutral) and its Stochastic is 65 (neutral).
CDLX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.0 | Oversold |
| Stochastic | 5.9 | Oversold |
CDLX's weekly RSI is 28 (oversold) and its Stochastic is 6 (oversold).
AMC PE vs Communication Services Sector
AMC has no meaningful PE right now: it lost money over the past year.
CDLX PE vs Communication Services Sector
CDLX has no meaningful PE right now: it lost money over the past year.
AMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 11% above |
| 20 week MA | $2.64 | 27% above |
| 50 week MA | $2.01 | 66% above |
| 100 week MA | $2.53 | 32% above |
| 200 week MA | $10.9 | 69% below |
AMC has the edge over CDLX on trend strength, trading above more of its moving averages.
CDLX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.11 | 32% below |
| 20 week MA | $3.25 | 56% below |
| 50 week MA | $6.64 | 78% below |
| 100 week MA | $13.8 | 90% below |
| 200 week MA | $46.7 | 97% below |
CDLX is in a downtrend: it's below all five of its weekly moving averages, and 97% below its 200-week average.
AMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $12.6 | -66% |
| 2021 | $12.6 | $142.6 | +1036% |
| 2022 | $142.6 | $44.0 | -69% |
| 2023 | $44.0 | $6.12 | -86% |
| 2024 | $6.12 | $4.00 | -35% |
| 2025 | $4.00 | $1.69 | -58% |
| 2026 YTD | $1.69 | $3.34 | +98% |
AMC has the edge over CDLX on returns for 2026, with the stronger performance.
CDLX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $649.6 | $1,430.2 | +120% |
| 2021 | $1,430.2 | $662.5 | -54% |
| 2022 | $662.5 | $48.2 | -93% |
| 2023 | $48.2 | $92.1 | +91% |
| 2024 | $92.1 | $37.3 | -60% |
| 2025 | $37.3 | $11.9 | -68% |
| 2026 YTD | $11.9 | $1.43 | -88% |
CDLX's yearly returns have swung widely, from +120% in 2020 to −93% in 2022. It's down 88% so far in 2026.